Immix Biopharma Inc (NASDAQ: IMMX) kicked off on Friday, up 14.88% from the previous trading day, before settling in for the closing price of $4.84. Over the past 52 weeks, IMMX has traded in a range of $1.34-$5.08.
Annual sales at Healthcare sector company slipped by -43.61% over the past five years. While this was happening, its average annual earnings per share was recorded -3.50%. With a float of $19.54 million, this company’s outstanding shares have now reached $33.04 million.
Immix Biopharma Inc (IMMX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Immix Biopharma Inc is 41.80%, while institutional ownership is 8.61%. The most recent insider transaction that took place on Sep 17 ’25, was worth 5,050. In this transaction CEO and Chairman of this company bought 2,500 shares at a rate of $2.02, taking the stock ownership to the 1,140,937 shares. Before that another transaction happened on Sep 16 ’25, when Company’s CFO bought 2,600 for $1.97, making the entire transaction worth $5,122. This insider now owns 290,659 shares in total.
Immix Biopharma Inc (IMMX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.15 earnings per share (EPS), higher than consensus estimate (set at -0.25) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
Immix Biopharma Inc (NASDAQ: IMMX) Trading Performance Indicators
Take a look at Immix Biopharma Inc’s (IMMX) current performance indicators. Last quarter, stock had a quick ratio of 1.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of Immix Biopharma Inc (IMMX)
Immix Biopharma Inc (NASDAQ: IMMX) saw its 5-day average volume 0.74 million, a positive change from its year-to-date volume of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 77.70%.
During the past 100 days, Immix Biopharma Inc’s (IMMX) raw stochastic average was set at 99.72%, which indicates a significant increase from 99.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.45 in the past 14 days, which was higher than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.35, while its 200-day Moving Average is $2.43. Nevertheless, the first resistance level for the watch stands at $5.84 in the near term. At $6.11, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.66. If the price goes on to break the first support level at $5.02, it is likely to go to the next support level at $4.47. The third support level lies at $4.20 if the price breaches the second support level.
Immix Biopharma Inc (NASDAQ: IMMX) Key Stats
The company with the Market Capitalisation of 186.69 million has total of 33,578K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -21,610 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -7,590 K.
